The Coming Collapse of the Middle Class
April 30, 2010 by biotechconnection.com · 24 Comments
Distinguished law scholar Elizabeth Warren teaches contract law, bankruptcy, and commercial law at Harvard Law School. She is an outspoken critic of America’s credit economy, which she has linked to the continuing rise in bankruptcy among the middle-class. Series: “UC Berkeley Graduate Council Lectures” [6/2007] [Public Affairs] [Business] [Show ID: 12620]
Changes Coming To The Djia?
March 10, 2010 by biotechconnection.com · Leave a Comment
Are changes coming soon to the Dow Jones Industrial Average Components?
By my reckoning, there currently are 5 DJIA Components of the 30 total trading under $10/share: Alcoa (AA), Bank of America (BAC), Citigroup (C), General Electric (GE), and General Motors (GM). Are changes to the Index imminent, and what are likely replacements?
In my view, it [...]
Jon Kabat-Zinn: Coming to Our Senses
February 28, 2010 by biotechconnection.com · 25 Comments
Renowned mindfulness meditation teacher and best-selling author Jon Kabat-Zinn speaks at UCSD Medical Center on the topic of “Coming to Our Senses”, which is also the name of his new book, subtitled “Healing Ourselves and the World Through Mindfulness”. A pioneer in the application of ancient Buddhist practices to healing in modern medical settings, Kabat-Zinn [...]
The Coming Biotech Age: The Business of Bio-Materials
February 24, 2010 by biotechconnection.com · 5 Comments
Product DescriptionThe age of Biotech is dawning, says BusinessWeek. Here’s how companies will benefit from the coming revolution in biotechnology. Biotech companies are quickly becoming the new economic engines of growth and innovationand when they explode, the Internet revolution will look like small potatoes. Businesses must prepare now for the post-information Biotech Age, and this [...]
The Biotech Investor: How to Profit from the Coming Boom in Biotechnology
February 23, 2010 by biotechconnection.com · 4 Comments
Product DescriptionIn The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for – tracking the effect of breaking [...]